Processa to Join Russell Microcap Index

The membership of FTSE Russell's Russell indexes is determined mainly by objective market-capitalization rankings and style criteria.

FREMONT, CA: Processa Pharmaceuticals, a clinical-stage biopharmaceutical firm developing products to improve the survival and quality of life for patients who have unmet medical requirements is set to join the Russell MicrocapIndex following the 2021 Russell indexes annual reconstitution effect after the U.S. market opens on June 28, according to a preliminary list of attachments posted June 4.

A one-year membership in the Russell Microcap Index entitles one to automatic participation in the appropriate growth and value style indexes. The membership of FTSE Russell's Russell indexes is determined mainly by objective market-capitalization rankings and style criteria.

"Inclusion in this index is an important milestone for our company, one that we believe will increase our exposure within the investment community and provide us with a meaningful opportunity to reach new investors, particularly those who use the Russell indexes to benchmark their portfolios," said Dr. David Young, CEO, and Chairman, Processa.

Investment managers and institutional investors employ Russell indexes for index funds and as benchmarks for active investment strategies. Russell’s U.S. indices are used to benchmark about 10.6 trillion dollars in assets. FTSE Russell, a famous global index provider, produces Russell indexes.